Pros: Full-body panels cover key areas like cardiovascular, liver, and metabolic health
Demand for GLP 1 medications, including semaglutide-based treatments such as Wegovy, Ozempic, and competing drugs from Eli Lilly, has surged globally
The infrastructure to deliver itsupply chain, trained providers, accessible pharmacy optionsis what needs to catch up
At 0.25 mg, the activation is partial
Defined by WHO as BMI 30 kg/m2 or 27.5kg/m2 for Asian populations * 1 BILLION INDIVIDUALS globally are now living with obesity (504 million adult women,374 million adult men, and 159 million children and adolescents) Data show targeting obesity mitigates the risk of cardiovascular adverse events, including ASCVD, heart failure hospitalizations, and chronic kidney disease, as well as MASH and obstructive sleep apnea I am so proud to contribute to this statement from iCARDIO Alliance on the Global Implementation Guidelines for the Management of Obesity